Affimed Therapeutics AG

Activities: Ingredients Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Affimed Therapeutics appoints Chief Medical Officer

Jens-Peter Marschner joins the firm from Merck KGaA
Ingredients

Affimed reorganises management team

Adi Hoess becomes chief executive
Research & Development

Novel paths to treating rare diseases

Biotechnology is providing new pathways to treatments for many uncommon yet life-threatening diseases. Dr Sarah Houlton looks at some promising candidates
Ingredients

Affimed Therapeutics hires chief commercial officer

Adi Hoess joins the Heidelberg-based firm
Subscribe now